ZEPOSIA ONCE-DAILY OZANIMOD
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Feb 2026)
What this means for you
This application is over — abandoned 02 Feb 2026. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97060574
- Mark type
- Design + words
- Filed
- 05 Oct 2021
- Published for opposition
- 07 Nov 2023
- Abandoned
- 02 Feb 2026
- Attorney of record
- Xiomara Triana
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of leukemia, auto inflammatory disease, autoimmune disease, blood disease, cancer, multiple sclerosis, ulcerative colitis, arthritis, musculoskeletal and skin diseases; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; all of the foregoing being immunomodulators
Owner
- Receptos LLC, Princeton, NJ, US
- Receptos LLC, New York, NY, US
Prosecution history
- 02 Feb 2026 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Feb 2026 — ABANDONMENT - NO USE STATEMENT FILED
- 01 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jun 2025 — SOU EXTENSION 3 GRANTED
- 30 Jun 2025 — SOU EXTENSION 3 FILED
- 30 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Dec 2024 — SOU EXTENSION 2 GRANTED
- 24 Dec 2024 — SOU EXTENSION 2 FILED
- 24 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 19 Sept 2024 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 19 Sept 2024 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 28 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jun 2024 — SOU EXTENSION 1 GRANTED